• Metadoro
  • 产品
  • 新闻和分析

新闻和分析

查看社区成员分享的市场见解
14.01.2025
Merck Becomes Interesting to Be Added to a Portfolio

Merck & Co (MRK) stocks have shown signs of becoming a compelling buy opportunity. Over the past six months, the stock has been in a downtrend, declining 29.8% to $94.50 per share. However, since mid-November, MRK has demonstrated a reversal of momentum, rebounding by 10.0% to reach $104.87 on December 5. Following a brief pullback and consolidation period, the stock has retested the downtrend resistance and appears poised to continue its upward trajectory.

With prices currently positioned to target $110.00, this represents a potential 9-10% upside from the present levels. Setting a stop-loss at $93.50 aligns with a prudent risk management strategy, providing protection against further downside while allowing for upside potential. The recent consolidation phase further supports the case for a breakout, making this an attractive moment to consider initiating or adding to a position in MRK.

14.01.2025
Tezos Is Seen Hodling above $1.200

Tezos (XTZ) has declined slightly by 0.2% this week, trading at $1.249, following Bitcoin’s (BTC) drop to $89,158, which triggered widespread altcoin sell-offs due to concerns of a potential further decline in BTC to $80,000. However, Bitcoin managed to hold above the critical support level at $89,000-$91,000, offering some relief to the broader crypto market.

Speculation about a shift in U.S. trade policy has provided additional support to crypto assets. Reports suggest the new U.S. administration may pursue a gradual increase in tariffs rather than an abrupt hike, which could help alleviate inflationary pressures and lead to a less aggressive monetary stance from the Federal Reserve.

This development is a positive signal for the cryptocurrency market and may help Tezos maintain its position above the key support level of $1.200.

09.01.2025
VeChain Is Suffering on Rising Borrowing Costs

VeChain (VET) has fallen 12.7% this week, trading at $0.0445, underperforming the broader cryptocurrency market. Bitcoin (BTC), the leading cryptocurrency, has declined by 5.6% to $93,220, with bearish momentum building as it approaches key support at $89,000-$91,000. This decline is largely attributed to tightening monetary conditions in the United States, which continue to weigh on risk assets. Investor confidence is further shaken by significant net outflows from spot BTC-ETFs, which lost $583 million on Wednesday, marking the second-largest single-day outflow on record.

If BTC falls below the critical support level of $89,000-$91,000, VeChain is likely to extend its losses, with prices potentially declining another 10% to $0.0400. A sustained drop in BTC could push VET even lower, towards $0.0300. Conversely, a strong rebound in BTC prices to the $100,000 level could drive VET back up to $0.0500, representing a recovery of approximately 12% from current levels.

16.01.2025
Delta Is Taking Off To Update Its Highs

Delta Air Lines stock rose markedly by low double digits in the first ten days of the new year. The U.S. carrier has served more than 200 million customers in 2024, when it was also recognized by J.D. Power, a leading American data analytics and consumer intelligence company, for being No. 1 in First/Business and Premium Economy Passenger Satisfaction. Travelers became more willing to spend extra money for swanky seats when meeting a high level of service. Delta is just positioning itself as the nation's premium airline. And what's more important, its Christmas quarter's earnings reportedly surpassed average analyst pool projections. Driven by stronger travel demand, smart financial management and capacity discipline, Delta business provided last three-months' profit of $1.85 per share vs $1.28 at the same period one year ago, compared to $1.75 in consensus estimates. On January 10, the airline industry leader put its future profit levels within a range between $0.70 and $1 per share in the current quarter through the end of March, while analyst expectations were focused on $0.77 cents, according to data compiled by LSEG. The starting months of each year always perform worse. It is clear that all carriers made losses in the Covid years of 2020-2022, but Delta profits only recovered into a range from $0.25 to $0.45 in the first quarter of 2023 and 2024, respectively, but Q1 profit numbers varied from $0.75 to $0.96 even in the three blessed years before the pandemic. Delta added that it is forecasting annual earnings in excess of $7.35 a share, which would be the highest in its 100-year history, based on its planned revenue growth of 7% to 9% in the March quarter from a year ago. The announcement could be compared to an adjusted profit of $6.16 a share in 2024. The company happily breaks through ticket prices' rising effects, almost undisturbed by a reduction in airline seats in the domestic market, which was peculiar for most carriers. Thus, new expectations created a fertile ground for setting new price records, even though price movements on Delta charts look most convincing among its other American rivals.

By the way, Citigroup analysts freshly updated their outlook on Delta Air Lines shares to raise their price target to $80 from the previous $77, vs the actual range around $65 per share where the stock just came after a reasonable market correction from last week's and all-time highs. Citigroup said it has included factors like higher revenue per available seat mile, projections of slightly lower fuel prices, increased taxation, a minor rise in share count, and the incorporation of fourth-quarter 2024 results into their financial model, which has projected Delta's profit at $7.49 per share in 2024 and $8.72 in 2025. Delta shares are Buy-rated at Citi, and we agree with their positive estimates in general, while keeping in mind even better price goals somewhere between $82.5 and $85.

23.01.2025
Ontology Is Sliding Towards $0.2000

Ontology (ONT) is down 2.3% this week, trading at $0.2176, in line with the broader crypto market where Bitcoin (BTC) has declined 2.0% to $101,632. While the new U.S. administration has made some strides toward fairer crypto regulation, Donald Trump has remained silent on the highly anticipated issue of adding Bitcoin to U.S. federal reserves.

Market speculation is rampant, with figures like BlackRock CEO Larry Fink suggesting Bitcoin could surge to $700,000 per coin if sovereign wealth funds begin accumulating. Other forecasts predict Bitcoin reaching $250,000 by year-end. While such projections could foster optimism, the lack of decisive action or announcements regarding U.S. crypto reserves is weighing heavily on the market.

For Ontology, the situation remains bearish. Having breached the critical support at $0.2500 last week, the token is now approaching the $0.2000 level. A failure to provide clear evidence or statements about U.S. federal crypto reserve plans could see ONT fall even further, breaching the $0.2000 mark and deepening its losses.

Rafael Quintana Martinez
Money Manager de alto rendimiento, con una sólida formación académica, profesional y de campo. Más de 9 años de experiencia especializada en el comercio de mercados financieros internacionales. La devoción, la fiabilidad, la responsabilidad y la ética impulsan mi vida. Actualmente me desempeño como Analista Senior para Metadoro. https://metadoro.com/es https://mx.investing.com/members/contributors/235587671/ https://es.tradingview.com/chart/EURUSD/rE9gVips/
DOGE Expected to Move Sideways as Long as BTC Is Above $90,000

Dogecoin (DOGE) is up 6.3% this week, trading at $0.3335 and outperforming the broader cryptocurrency market, where Bitcoin (BTC) has gained 3.3% to $98,360. DOGE’s correction found support at $0.3000, although prices briefly dipped as low as $0.2622 before recovering.

The resurgence in DOGE can be attributed to Bitcoin's recovery and its ongoing association with Elon Musk, which continues to bolster investor sentiment. As long as Bitcoin remains above the $90,000 mark, DOGE is likely to maintain support above $0.3000 and could potentially rally further to $0.4000.

However, further upside for DOGE appears limited unless Bitcoin alleviates its extreme overbought conditions.

2727
Rafael Quintana Martinez
Money Manager de alto rendimiento, con una sólida formación académica, profesional y de campo. Más de 9 años de experiencia especializada en el comercio de mercados financieros internacionales. La devoción, la fiabilidad, la responsabilidad y la ética impulsan mi vida. Actualmente me desempeño como Analista Senior para Metadoro. https://metadoro.com/es https://mx.investing.com/members/contributors/235587671/ https://es.tradingview.com/chart/EURUSD/rE9gVips/
REN Is Likely to Continue Down

Ren (REN) has gained 4.5% this week, trading at $0.0299, outperforming the broader cryptocurrency market, where Bitcoin (BTC) has lost 1.0%, settling at $94,187. Despite the weekly uptick, REN continues to face significant headwinds. Binance delisted the token on December 10, triggering a sharp decline, which even the introduction of the Ren v2 update failed to counteract.

REN's price dipped to $0.0260 on December 20, coming close to the critical support level at $0.0250. While a technical rebound is possible, the altcoin currently lacks fundamental drivers to sustain an upward move. If the broader crypto market experiences further downside pressure, REN risks falling even lower, potentially testing the next key support at $0.0125.

3397
Rafael Quintana Martinez
Money Manager de alto rendimiento, con una sólida formación académica, profesional y de campo. Más de 9 años de experiencia especializada en el comercio de mercados financieros internacionales. La devoción, la fiabilidad, la responsabilidad y la ética impulsan mi vida. Actualmente me desempeño como Analista Senior para Metadoro. https://metadoro.com/es https://mx.investing.com/members/contributors/235587671/ https://es.tradingview.com/chart/EURUSD/rE9gVips/
Pfizer Rejoice the Santa Rally

Pfizer (PFE) stocks are showing strong signs of recovery after a significant decline over the past three years. Prices dropped by 60.0% from $61.66 in December 2021 to $24.44 in mid-November 2024, reaching levels not seen since December 2012. Considering inflation, the company’s newly acquired patents, and its lineup of medications, the stock appears deeply undervalued.

Since hitting its November lows, PFE has rebounded by 9.0%, reaching $26.68. The stock has successfully broken through trend resistance and retested it, signaling potential for further gains. With the Santa rally underway and momentum likely to carry into January, PFE looks poised for additional upside.

Buying PFE at $26.00-27.00 offers an attractive opportunity. The target range is $31.00-32.00, representing a potential upside of 19.0-20.0%. A stop-loss at $23.00 is recommended to manage downside risk.

2883
Market Trending Ahead of Christmas

When the pre-Christmas week was just beginning, the global investment sentiment had been fuelled by record-breaking earnings of a great chipmaker for gadgets and data centers Broadcom. The bullish appetites were sparked as that was the last big tech company to report before the year-end, and it luckily projected a better trend for chip demand from flagship customers like Apple, Samsung, Huawei and Cisco.

The value of Broadcom added more than 35% within a couple of trading days to hit $1 trillion or over $250 per share. This was around an annual target area for the firm according to estimates of many reputable investing houses. The tech-heavy Nasdaq Composite index exceeded a psychological mark of 20,000 points.

The two achievements in sync prompted a natural wave of massive profit taking by a happy but still wary crowd, due to much weaker prospects provided by some other AI era leaders like Adobe and Oracle, especially ahead of the last Federal Reserve’s policy decision in 2024. Thus, the widespread stock rally was stopped and faced an even deeper 3% retracement from fresh peaks in terms of the S&P 500 broad market barometer. The S&P 500 had to retrace from above 6,050 to below 5,850 points on Wednesday night of December 18, as a response to the U.S. central bank’s relentless remarks. Its chair Jerome Powell clarified that policymakers shifted their road map from previously supposed three or four interest rate cut moves to only two small 0.25% steps to lower borrowing costs in a very narrow and careful way. Too high levels of normalised rates restrict access to cheap credit resources, being negative for stocks, yet this impact is limited in time and scale due to a solid labour market, hopes for soft landing, running away from inflation to assets and lower rates in other countries. A rate differential factor is also boosting yields of the U.S. public debt, which led the Greenback index to fresh 24-month highs above 108 points, suppressing gold prices.

3061
59

加入我们的社区

分享您的专业和业余观察,交流经验,预测发展

类别
全部
Stocks
Crypto
Etf
Commodities
Indices
Currencies
Energies
Metals
工具
工具
全部
Metadoro
投稿人